Roundtable Discussion: DNA at Speed: Compressing Development Cycles for Individualized Vaccine Development to Beat Critical Timelines
- Accelerating biopsy-to-product timelines to meet urgent patient needs
- Ensuring DNA integrity, purity, and rapid synthesis for personalized treatments
- Leveraging AI, automation, and synthetic DNA to shorten development cycles